Skip to Main Content

Webinar

Leveraging Engineering Simulation in the Development of Vaccine Delivery Devices

Intranasal delivery can provide better protection than traditional injected vaccines for diseases such as influenza due to mucosal and cross-protection. But current intranasal delivery technology uses expensive and difficult-to-manufacture vaccines inefficiently. Creare has recently developed two novel vaccine delivery devices: a dry powder inhaler (DPI), which effectively delivers the vaccine dose to targeted regions of the nasal tract; and an ultra-compact InVaxTM intranasal nebulizer for liquid vaccines, which is an optimal platform for large-scale influenza vaccination.

Learn how Creare used Ansys Fluent for aerodynamic design and nasal deposition modeling in support of the DPI device development. Discover how analyses performed with Ansys Mechanical were used to design the piezoelectric actuator, a key component in the aerosol generation process for the InVax device.

 

SHARE THIS WEBINAR

不可能を可能にする準備は整っていますか?

お問い合わせ

* = 必須項目

お問い合わせいただき、ありがとうございます。

We’re here to answer your questions and look forward to speaking with you. A member of our Ansys sales team will contact you shortly.